FDA approves new drug for rare form of rickets
On April 17, the U.S. Food and Drug Administration (FDA) approved Crysvita (burosumab), the first drug approved to treat adults and children ages 1…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.